4//SEC Filing
Ordonez Claudia 4
Accession 0001209191-21-040648
CIK 0001664710other
Filed
Jun 14, 8:00 PM ET
Accepted
Jun 15, 5:01 PM ET
Size
11.2 KB
Accession
0001209191-21-040648
Insider Transaction Report
Form 4
Ordonez Claudia
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2021-06-11$0.48/sh+1,000$480→ 1,000 total - Sale
Common Stock
2021-06-11$50.48/sh−653$32,963→ 347 total - Sale
Common Stock
2021-06-11$51.95/sh−347$18,027→ 0 total - Exercise/Conversion
Employee Stock Option (right to buy)
2021-06-11−1,000→ 98,211 totalExercise: $0.48Exp: 2029-09-18→ Common Stock (1,000 underlying)
Footnotes (4)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.15 to $51.10 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3).
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.63 to $52.21 inclusive.
- [F4]One-quarter (1/4th) of the shares subject to the option shall vest on September 16, 2020, and one-twelfth (1/12th) of the remaining shares subject to the option shall vest in equal quarterly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.
Documents
Issuer
Keros Therapeutics, Inc.
CIK 0001664710
Entity typeother
Related Parties
1- filerCIK 0001808290
Filing Metadata
- Form type
- 4
- Filed
- Jun 14, 8:00 PM ET
- Accepted
- Jun 15, 5:01 PM ET
- Size
- 11.2 KB